• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于脂质组学的机器学习快速诊断对头颈部癌症中 TGF-β 信号激活区域的检测。

Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer.

机构信息

Department of Otolaryngology, Head and Neck Surgery, Chuo-city, Japan.

Center for Medical Education and Sciences, Chuo-city, Japan.

出版信息

Br J Cancer. 2020 Mar;122(7):995-1004. doi: 10.1038/s41416-020-0732-y. Epub 2020 Feb 5.

DOI:10.1038/s41416-020-0732-y
PMID:32020064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7109155/
Abstract

BACKGROUND

Several pro-oncogenic signals, including transforming growth factor beta (TGF-β) signalling from tumour microenvironment, generate intratumoural phenotypic heterogeneity and result in tumour progression and treatment failure. However, the precise diagnosis for tumour areas containing subclones with cytokine-induced malignant properties remains clinically challenging.

METHODS

We established a rapid diagnostic system based on the combination of probe electrospray ionisation-mass spectrometry (PESI-MS) and machine learning without the aid of immunohistological and biochemical procedures to identify tumour areas with heterogeneous TGF-β signalling status in head and neck squamous cell carcinoma (HNSCC). A total of 240 and 90 mass spectra were obtained from TGF-β-unstimulated and -stimulated HNSCC cells, respectively, by PESI-MS and were used for the construction of a diagnostic system based on lipidome.

RESULTS

This discriminant algorithm achieved 98.79% accuracy in discrimination of TGF-β1-stimulated cells from untreated cells. In clinical human HNSCC tissues, this approach achieved determination of tumour areas with activated TGF-β signalling as efficiently as a conventional histopathological assessment using phosphorylated-SMAD2 staining. Furthermore, several altered peaks on mass spectra were identified as phosphatidylcholine species in TGF-β-stimulated HNSCC cells.

CONCLUSIONS

This diagnostic system combined with PESI-MS and machine learning encourages us to clinically diagnose intratumoural phenotypic heterogeneity induced by TGF-β.

摘要

背景

包括肿瘤微环境中的转化生长因子β(TGF-β)信号在内的几种致癌信号会产生肿瘤内表型异质性,导致肿瘤进展和治疗失败。然而,精确诊断含有细胞因子诱导恶性特征的亚克隆的肿瘤区域在临床上仍然具有挑战性。

方法

我们建立了一种快速诊断系统,该系统基于探针电喷雾电离-质谱(PESI-MS)和机器学习的组合,无需免疫组织化学和生化程序即可识别头颈部鳞状细胞癌(HNSCC)中具有异质性 TGF-β 信号状态的肿瘤区域。通过 PESI-MS 分别从未刺激和刺激的 HNSCC 细胞中获得了 240 和 90 个质谱,用于构建基于脂质组学的诊断系统。

结果

该判别算法在区分 TGF-β1 刺激的细胞与未处理的细胞方面达到了 98.79%的准确率。在临床人类 HNSCC 组织中,该方法在确定激活 TGF-β 信号的肿瘤区域方面的效率与使用磷酸化-SMAD2 染色的传统组织病理学评估相当。此外,在 TGF-β 刺激的 HNSCC 细胞中,质谱上的几个改变的峰被鉴定为磷酸胆碱。

结论

该与 PESI-MS 和机器学习相结合的诊断系统鼓励我们对 TGF-β 诱导的肿瘤内表型异质性进行临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f5e/7109155/0ca06fbc60b8/41416_2020_732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f5e/7109155/bf87c2fd2418/41416_2020_732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f5e/7109155/0ca06fbc60b8/41416_2020_732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f5e/7109155/bf87c2fd2418/41416_2020_732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f5e/7109155/0ca06fbc60b8/41416_2020_732_Fig3_HTML.jpg

相似文献

1
Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer.基于脂质组学的机器学习快速诊断对头颈部癌症中 TGF-β 信号激活区域的检测。
Br J Cancer. 2020 Mar;122(7):995-1004. doi: 10.1038/s41416-020-0732-y. Epub 2020 Feb 5.
2
Construction of mass spectra database and diagnosis algorithm for head and neck squamous cell carcinoma.构建头颈部鳞状细胞癌的质谱数据库和诊断算法。
Oral Oncol. 2017 Dec;75:111-119. doi: 10.1016/j.oraloncology.2017.11.008. Epub 2017 Nov 10.
3
Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines.在人头颈部癌细胞系中,TGF-β信号通路多个组分的缺陷导致TGF-β1诱导的Smad信号传导失调。
Int J Oncol. 2006 May;28(5):1279-85.
4
Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.人类头颈部鳞状细胞癌中Smad信号通路的频繁改变:组织芯片分析
Oncol Res. 2003;14(2):61-73. doi: 10.3727/000000003108748612.
5
Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.五种频繁甲基化基因对转化生长因子-β信号的破坏导致头颈部鳞状细胞癌的发病机制。
Cancer Res. 2009 Dec 15;69(24):9301-5. doi: 10.1158/0008-5472.CAN-09-3073.
6
Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.头颈部鳞状细胞癌中转化生长因子β信号通路存在缺陷,这可由活化型Smad2表达缺失得以证实。
Clin Cancer Res. 2001 Jun;7(6):1618-26.
7
Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.16型人乳头瘤病毒阳性与16型人乳头瘤病毒阴性头颈部鳞状细胞癌中Smad4表达的差异
Clin Cancer Res. 2005 May 1;11(9):3191-7. doi: 10.1158/1078-0432.CCR-04-1299.
8
Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.头颈部鳞状细胞癌中转化生长因子β-Smad信号通路的破坏,由SMAD2和SMAD4突变证实。
Cancer Lett. 2007 Jan 8;245(1-2):163-70. doi: 10.1016/j.canlet.2006.01.003. Epub 2006 Feb 14.
9
Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.通过生物信息学方法鉴定和验证头颈部鳞状细胞癌中 TGF-β 相关的长非编码 RNA。
J Transl Med. 2018 Feb 28;16(1):46. doi: 10.1186/s12967-018-1418-6.
10
CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling.CXCR7 通过上调 TGF-β1/Smad2/3 信号通路促进头颈部鳞状细胞癌的迁移和侵袭。
Sci Rep. 2019 Dec 2;9(1):18100. doi: 10.1038/s41598-019-54705-x.

引用本文的文献

1
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.人工智能在癌症诊断和治疗中的新研究与未来展望。
J Hematol Oncol. 2023 Nov 27;16(1):114. doi: 10.1186/s13045-023-01514-5.
2
High-performance Collective Biomarker from Liquid Biopsy for Diagnosis of Pancreatic Cancer Based on Mass Spectrometry and Machine Learning.基于质谱和机器学习的用于胰腺癌诊断的液体活检高性能集体生物标志物
J Cancer. 2021 Nov 4;12(24):7477-7487. doi: 10.7150/jca.63244. eCollection 2021.
3
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey.
面向针对个性化治疗的医学应用的机器学习预测的可解释性:一项癌症病例调查。
Int J Mol Sci. 2021 Apr 22;22(9):4394. doi: 10.3390/ijms22094394.
4
Diagnostic significance of plasma lipid markers and machine learning-based algorithm for gastric cancer.血浆脂质标志物及基于机器学习的算法对胃癌的诊断意义
Oncol Lett. 2021 May;21(5):405. doi: 10.3892/ol.2021.12666. Epub 2021 Mar 22.
5
Recent Advances in the Application of Artificial Intelligence in Otorhinolaryngology-Head and Neck Surgery.人工智能在耳鼻咽喉头颈外科应用的最新进展
Clin Exp Otorhinolaryngol. 2020 Nov;13(4):326-339. doi: 10.21053/ceo.2020.00654. Epub 2020 Jun 18.